| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 88.48B | 84.19B | 73.69B | 61.03B | 56.91B | 54.87B |
| Gross Profit | 19.41B | 17.14B | 12.44B | 9.31B | 8.84B | 7.65B |
| EBITDA | 11.71B | 10.04B | 6.16B | 3.52B | 3.38B | 2.06B |
| Net Income | 8.34B | 7.26B | 4.51B | 2.34B | 2.24B | 1.23B |
Balance Sheet | ||||||
| Total Assets | 78.42B | 80.16B | 76.23B | 63.46B | 63.70B | 62.44B |
| Cash, Cash Equivalents and Short-Term Investments | 18.01B | 12.77B | 10.02B | 13.26B | 14.87B | 14.82B |
| Total Debt | 810.00M | 65.00M | 125.00M | 65.00M | 165.00M | 121.00M |
| Total Liabilities | 24.89B | 27.21B | 27.04B | 20.08B | 21.23B | 21.16B |
| Stockholders Equity | 53.53B | 52.95B | 49.19B | 43.38B | 42.46B | 41.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.45B | -1.60B | -308.00M | 659.00M | 712.00M |
| Operating Cash Flow | 0.00 | 4.65B | -1.45B | -157.00M | 904.00M | 1.14B |
| Investing Cash Flow | 0.00 | -159.00M | -340.00M | -625.00M | -130.00M | -1.29B |
| Financing Cash Flow | 0.00 | -1.79B | -1.72B | -883.00M | -565.00M | -1.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥171.83B | 11.69 | ― | 2.81% | 8.83% | 49.49% | |
76 Outperform | ¥259.31B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
72 Outperform | ¥699.53B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
70 Outperform | ¥127.11B | 9.59 | ― | 1.55% | 20.44% | 106.45% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥54.87B | 11.64 | ― | 2.95% | -7.98% | 37.92% | |
48 Neutral | ¥70.97B | -149.33 | ― | 2.73% | -3.59% | 49.34% |